Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Trying to get to the truth of contract service provider claims
November 10, 2010
By: Mak Jawadekar
Contributing Editor
How do you get a potential contract service providerto give you a true list of its
acknowledged capabilities prior to an audit?
For anyone on the sponsor (pharmaceutical company) side of the equation, the bottom line of what one is looking for from a potential contract service provider is a priori ‘Proven Validation of Robust-Promise’ (PVRP) of potential success for any outsourcing project. They want to see the same transparency, quality and speed at better costs than if they were to executing the project internally.
We oftentimes get to see so much advertising with ‘glossy’ photos of the equipment, buildings, staff and other descriptions of what the service provider can do for us. At times, when you drill down to specific details, you get to see the real picture. I have noticed a tendency among providers to say, “We do it all under one roof.” However, after further teleconferences, you find out that there are many gaps in what is being presented to you. When you question the service provider about these lacunae, at times you hear that they provide these services through “another partner” (that is, a sub-contractor).
Wouldn’t it be nice to have a picture of reality presented upfront rather than the having to find out via thorough questioning – almost a hostile interrogation – of the service provider? I would love to get a “peer review” from other sponsor companies before venturing to work with a service provider. You may never get to hear or read such “reviews” published in an open forum; as I’ve mentioned in a previous column, a brief private conversation with a peer during a conference break may help provide that validation one is always looking for.
Prior to commissioning an audit – either a QA audit or just an informal one – before commissioning of project work, it always helps if the service provider provides the following: references and a list of equipment/instrumentation that has gone through rigor of validation and reviews. Also, it helpsto get a ‘virtual tour’ of the facilities posted through a website. It’s a bonus if the service provider provides a list oftechnologies/special capabilities that it provides to its clients, for use, (exclusive or non-exclusive) licensing or for the sponsor’s benefit.
For a contract manufacturing service provider, it also helps, for example, if packaging capabilities are in house, along with capability to do site stability programs. In reality, it makes everyone’s job easier if everything is provided upfront. If any FDA audits have been performed, the audit reports are quite useful. If there are any past regulatory issues, it is best if the service provider brings them to the attention of the sponsor company. It’s always good to know that the service provider has come out clean with all its regulatory agency audits in addition to other sponsor audits.
The sponsor’s representative is always looking for that ‘Robustness Promise’ that only comes from honest presentation of the provider’s credibility, capacity, scalability and capabilities at reasonable costs. It is always good to have a clear dialogue and application of science and technology to fulfill the sponsor’s needs. Ideally, I have found that having the appropriate people interacting with their counterparts from either side – and providing “undivided attention” to each other’s needs – always works the best.
Once the project gets started and continues, I also think that portraying an ongoing “dashboard” of activities, creating some kind of feedback mechanism – both ways – and constructing and maintaining a set of performance metrics always seem to provide priceless tools for continuous improvement of the sponsor-provider bond, as well as a blueprint for an ultimate successful relationship!
Makarand (Mak) Jawadekar most recently served as Director, Portfolio Management and Performance at Pfizer Global R&D,until February 2010, when he opted for an early retirement after28 years at Pfizer Inc. He currently serves on several companies’ advisory boards and also consults with bio/pharmaceutical companies for global outreach in emerging market regions. He can be reached at [email protected].
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !